Literature DB >> 24180411

Role of yeasts in healthy and impaired gut microbiota: the gut mycome.

Gianluca Ianiro, Giovanni Bruno, Loris Lopetuso, Francesca Bartoli Beghella, Lucrezia Laterza, Francesca D'Aversa, Giovanni Gigante, Giovanni Cammarota, Antonio Gasbarrini1.   

Abstract

Although several studies have been published on the gut microbiota composition, they are mainly focused on bacteria. Therefore, the world of gut yeasts, the "gut mycome", is still unclear. Over the last years, brand new gut microbiota analysis techniques have been applied to the study of yeasts, with exciting results both in health and in disease. A therapeutic potential for many gastrointestinal and extra-intestinal diseases has been recognized for selected yeast strains, such as Saccharomyces boulardii. This narrative review represents an overview of the new evidences regarding the "gut mycome".

Entities:  

Mesh:

Year:  2014        PMID: 24180411     DOI: 10.2174/13816128113196660723

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  16 in total

Review 1.  Fungi in the healthy human gastrointestinal tract.

Authors:  Heather E Hallen-Adams; Mallory J Suhr
Journal:  Virulence       Date:  2016-10-13       Impact factor: 5.882

Review 2.  Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.

Authors:  Antonella Gallo; Giovanna Passaro; Antonio Gasbarrini; Raffaele Landolfi; Massimo Montalto
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

Review 3.  The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.

Authors:  Stephen M Vindigni; Timothy L Zisman; David L Suskind; Christopher J Damman
Journal:  Therap Adv Gastroenterol       Date:  2016-04-19       Impact factor: 4.409

Review 4.  Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications.

Authors:  Alejandra de Moreno de LeBlanc; Jean Guy LeBlanc
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 5.  The gut virome in inflammatory bowel disease pathogenesis: From metagenomics to novel therapeutic approaches.

Authors:  Federica Ungaro; Luca Massimino; Silvia D'Alessio; Silvio Danese
Journal:  United European Gastroenterol J       Date:  2019-09-27       Impact factor: 4.623

Review 6.  Can probiotics benefit children with autism spectrum disorders?

Authors:  Fernando Navarro; Yuying Liu; Jon Marc Rhoads
Journal:  World J Gastroenterol       Date:  2016-12-14       Impact factor: 5.742

Review 7.  Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis.

Authors:  Giuseppe Losurdo; Rossella Cubisino; Michele Barone; Mariabeatrice Principi; Gioacchino Leandro; Enzo Ierardi; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2018-01-07       Impact factor: 5.742

8.  Multimodal Approach to Assessment of Fecal Microbiota Donors based on Three Complementary Methods.

Authors:  Jaroslaw Bilinski; Mikolaj Dziurzynski; Pawel Grzesiowski; Edyta Podsiadly; Anna Stelmaszczyk-Emmel; Tomasz Dzieciatkowski; Lukasz Dziewit; Grzegorz W Basak
Journal:  J Clin Med       Date:  2020-06-29       Impact factor: 4.241

9.  The lung mycobiome: an emerging field of the human respiratory microbiome.

Authors:  Linh D N Nguyen; Eric Viscogliosi; Laurence Delhaes
Journal:  Front Microbiol       Date:  2015-02-13       Impact factor: 5.640

Review 10.  Rebuilding the Gut Microbiota Ecosystem.

Authors:  Antonella Gagliardi; Valentina Totino; Fatima Cacciotti; Valerio Iebba; Bruna Neroni; Giulia Bonfiglio; Maria Trancassini; Claudio Passariello; Fabrizio Pantanella; Serena Schippa
Journal:  Int J Environ Res Public Health       Date:  2018-08-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.